Luisa De Cola | Drug Delivery Systems | Best Researcher Award

Luisa De Cola | Drug Delivery Systems | Best Researcher Award

Prof Luisa De Cola, University of Milan and Mario Negri Institute, Italy

Prof. Luisa De Cola is an accomplished chemist known for her interdisciplinary research in supramolecular and materials chemistry, with applications in biomedical fields. She holds a Laurea in Chemistry from the University of Messina and has held prestigious positions at institutions like the University of Amsterdam, University of Münster, and University of Strasbourg. Currently, she is a Full Professor at the University of Milan and Director of the “Materials for Health” unit at Istituto Mario Negri, Milan. With over 400 published papers and 42 patents, she has received numerous awards, including the 2020 Gold Medal “Giulio Natta” and 2014 Chevalier de la Légion d’Honneur. 🏅🔬💡

Publication Profile

Google Scholar

Education

Prof. Luisa De Cola, a renowned scientist, earned her Laurea in Chemistry from the University of Messina in 1983. She has held various prestigious academic roles, including Post-doctoral Fellow at Virginia Commonwealth University, and visiting scientist positions at UCLA, Harvard, and MIT. From 1986 to 1990, she worked as a researcher at the National Research Council in Bologna. She later served as a Full Professor at the University of Amsterdam, University of Münster, and University of Strasbourg. Currently, she is a Full Professor at the University of Milan and Director of the “Materials for Health” unit at the Mario Negri Institute. 🧪🔬🌍

Experience

Prof. Luisa De Cola is a renowned academic and researcher currently serving as a Full Professor at the University of Milan, Italy, since 2020. She is also the Director of the “Materials for Health” unit at Istituto di Ricerche Farmacologiche Mario Negri in Milan. Her distinguished career includes previous roles at prestigious institutions such as the University of Amsterdam, University of Münster, and University of Strasbourg. Prof. De Cola has held notable positions, including chairing molecular photonic materials and nanoelectronics. Her research contributions span nanoelectronics, nanophotonics, and biomaterials. 🌍📚🔬👩‍🔬

Research achievements

Prof. Luisa De Cola’s research is known for its multidisciplinary approach, driven by curiosity and fundamental exploration, often with practical applications. Her work spans supramolecular and material chemistry, focusing on functional luminescent and electro-luminescent assemblies, optical and electroluminescent devices, and dynamic (breakable) materials for biomedical applications. With over 400 published papers in peer-reviewed journals (H-index = 88, over 27,000 citations on Scopus), her research has been featured in prestigious journals like Nature and Nature Chemistry. Her contributions continue to shape innovations in materials science and biomedicine. 🌟🧪🔬📚💡💉

Peer recognition

Prof. Luisa De Cola is a distinguished chemist, awarded numerous prestigious prizes throughout her career. Her accolades include the 1993 Chemistry Prize from the Accademia di Scienze Fisiche e Matematiche di Napoli, the 1995 Federchimica National Prize, and the 2009 European Research Council Advanced Grant Award (Magic). In 2011, she received the IUPAC Prize for distinguished women in chemistry, followed by the 2014 Chevalier de la Légion d’Honneur. Other honors include the 2019 Izatt–Christensen Award, 2020 Giulio Natta Gold Medal, and the 2024 Centenary Prize for Chemistry and Communication. She is also an Honorary Professor at Tianjin University and a Doctor Honoris Causa from Universidad Internacional Menéndez Pelayo. 🏆🔬🎖️🌟

Research Focus

Prof. Luisa De Cola’s research focuses on advanced materials, particularly in the development of luminescent and electrochemical systems for various applications. Her work involves the synthesis and characterization of ruthenium and osmium complexes, often in multi-component systems, exploring their electrochemical behavior, absorption spectra, and photoinduced processes. She investigates biomimetic self-assembly for imaging applications, the creation of highly luminescent lanthanide complexes, and photoinduced energy and electron transfer in dinuclear complexes. Her studies have applications in photonic devices, electroluminescence, and molecular imaging. Her work intersects chemistry, material science, and biological applications. 🔬💡🔋✨

Publication Top Notes

Ruthenium (II) and osmium (II) bis (terpyridine) complexes in covalently-linked multicomponent systems: synthesis, electrochemical behavior, absorption spectra, and …

Controlling and imaging biomimetic self-assembly

White‐light emission from an assembly comprising luminescent iridium and europium complexes

Highly luminescent, triple-and quadruple-stranded, dinuclear Eu, Nd, and Sm (III) lanthanide complexes based on bis-diketonate ligands

When self-assembly meets biology: luminescent platinum complexes for imaging applications

Photoinduced energy and electron transfer processes in rigidly bridged dinuclear Ru/Os complexes

Electroluminescent device with reversible switching between red and green emission

 

YORINOBU MAEDA | Drug Delivery Systems | Pharmaceutical Advancement Award

YORINOBU MAEDA | Drug Delivery Systems | Pharmaceutical Advancement Award

Prof Dr YORINOBU MAEDA, Fukuyama university, Japan

Prof. Dr. Yorinobu Maeda, Ph.D. (Hiroshima University, 1990), is a renowned expert in drug safety, pharmacokinetics, and infection control. As a professor at Fukuyama University and Drug Safety Director, he has advanced renal function-based dosing and prescription optimization. His contributions have earned him multiple awards, including Best Paper Awards (2001, 2005) and an Academic Contribution Award (2014) from the Japanese Society of Pharmaceutical Health Care and Sciences. With a strong academic and clinical impact, Dr. Maeda is a leading figure in pharmaceutical advancements, ensuring better patient safety and treatment efficacy. 🏅🔬

Publication Profile

scopus

Educational and Professional Background

Prof. Dr. Yorinobu Maeda has a distinguished background in pharmaceutical sciences, earning his Ph.D. from Hiroshima University in 1990 🎓. His expertise spans infection control, hospital pharmacy specialization, and drug safety leadership, reflecting his dedication to pharmaceutical advancements 💊. With leadership roles in major hospitals 🏥 and an esteemed position as a professor at Fukuyama University 🎓, he has made significant academic and practical contributions to the field. His work continues to shape the future of pharmacy, ensuring patient safety and advancing healthcare practices for better medical outcomes 🌍🔬.

Contributions to Pharmaceutical Sciences

Prof. Dr. Yorinobu Maeda has made significant contributions to pharmaceutical sciences, particularly in drug safety, pharmacokinetics, and dosage optimization 💊🔬. His research focuses on infection control 🦠, renal function-based dosing 🏥, and improving prescription practices, directly enhancing patient safety and treatment efficacy 👨‍⚕️✅. As a Drug Safety Director, he plays a crucial role in advancing pharmaceutical practices, ensuring medications are used effectively and safely. His dedication to optimizing drug therapy and refining medical protocols continues to have a lasting impact on healthcare, improving outcomes for patients worldwide 🌍💉.

Awards and Recognitions

Prof. Dr. Yorinobu Maeda has made remarkable contributions to the field of pharmaceutical healthcare, earning numerous prestigious accolades from the Japanese Society of Pharmaceutical Health Care and Sciences. His achievements include the Best Paper Awards in 2001 and 2005 🏆, as well as the esteemed Academic Contribution Award in 2014 🎓. These honors highlight his dedication to advancing research and implementing pharmacokinetic principles to enhance patient safety and care 🩺. Dr. Maeda’s work stands as a testament to his unwavering commitment to improving healthcare standards and fostering innovation in pharmaceutical sciences. 🌟

Research Focus

Professor Dr. Yorinobu Maeda is an eminent researcher specializing in pharmaceutical sciences, with a primary focus on drug bioavailability, prodrug development, and therapeutic drug monitoring. His work spans areas such as drug absorption, small intestinal bacterial overgrowth diagnosis, and managing adverse drug reactions. Notable research includes the impact of metal ions on drug efficacy and innovative prodrug strategies. Through collaborative studies, he contributes to optimizing drug delivery systems and clinical pharmacotherapy, enhancing patient safety and treatment outcomes. 🧪💊

Publication Top Notes

5-Aminosalicylic Acid Distribution into the Intestinal Membrane Along the Gastrointestinal Tract After Oral Administration in Rats

Development and Evaluation of EDTA-Treated Rabbits for Bioavailability Study of Chelating Drugs Using Levofloxacin, Ciprofloxacin, Hemiacetal Ester Prodrugs, and Tetracycline

Diagnosis by Microbial Culture, Breath Tests and Urinary Excretion Tests, and Treatments of Small Intestinal Bacterial Overgrowth

Ester Prodrugs of Levofloxacin to Prevent Chelate Formation in Presence of Aluminium Ion

Study on the method to avoid infusion‑site adverse events following chemotherapeutic treatment with epirubicin and fosaprepitant using immortalized human umbilical vein endothelial cells

Effect of aluminium ion on bioavailability of levofloxacin following oral administration of cilexetil ester of levofloxacin as prodrug in rats

 

Liqun Jiang | Drug Delivery Systems | Best Researcher Award

Assist. Prof. Dr. Liqun Jiang | Drug Delivery Systems | Best Researcher Award

Xuzhou Medical University, China

Author Profile

🎓Early Academic Pursuits 

Liqun Jiang began his academic journey with a deep interest in pharmaceutical sciences and biotechnology. His foundational studies were driven by a passion for discovering innovative solutions to pressing medical challenges. During his early years, Jiang demonstrated exceptional aptitude in the fields of drug development and delivery systems, excelling in both theoretical and applied sciences. These formative experiences laid the groundwork for his future endeavors in advanced pharmaceutical research. Jiang’s dedication to academic excellence led him to pursue specialized training and advanced education, equipping him with the knowledge and skills essential for groundbreaking contributions to medical science.

🌟Professional Endeavors 

Currently serving as an Associate Professor at Xuzhou Medical University, Liqun Jiang has established himself as a key figure in pharmaceutical engineering. His role extends beyond teaching, as he actively participates in high-impact research initiatives. A youth member of the Pharmaceutical Engineering Committee of the Chinese Pharmaceutical Society, Jiang is deeply involved in projects focused on novel drug delivery systems, particularly for respiratory diseases.

He has been instrumental in nearly 10 prestigious research projects, including the national 863 Program and major drug innovation programs. Jiang has successfully overseen the development of approximately 10 products, ranging from pharmaceuticals and disinfection solutions to specialized medical foods. His collaborative efforts with pharmaceutical companies have led to the development of a drug liposome inhalation agent, which has now progressed to pilot production stages.

🔬Contributions and Research Focus 

Jiang Liqun’s research is primarily centered on novel drug delivery systems for respiratory diseases, with a particular emphasis on pulmonary edema. His contributions to the field are both diverse and impactful, including: Developing pressure-sensitive multivesicular liposomes for delivering amlodipine besylate, Innovating therapies with exogenous eNOS genes to combat high-altitude pulmonary edema, Utilizing mesenchymal stem cell exosomes for advanced inhalation therapies, Designing high-efficiency powder mist inhalants for high-altitude conditions.

🏆Accolades and Recognition 

Liqun Jiang’s academic and professional achievements have garnered widespread recognition. His research contributions are evidenced by: Nearly 30 peer-reviewed publications in reputed journals, 10 authorized patents, with 8 more under processing, An impressive citation index of 312, reflecting the high impact of his work, Close collaborations with pharmaceutical companies, leading to tangible advancements in drug development and commercialization, Jiang’s dedication to his field is further highlighted by his active participation in the Chinese Pharmaceutical Society, where he contributes as a youth member in shaping the future of pharmaceutical engineering.

🌏Impact and Influence 

Jiang Liqun’s work has had a profound impact on both academia and industry. His innovative strategies for addressing respiratory diseases have paved the way for safer, more effective therapeutic interventions. By integrating cutting-edge drug delivery systems into clinical practice, Jiang has set a benchmark in the treatment of pulmonary conditions. His ability to bridge the gap between research and application has made him a valuable collaborator for pharmaceutical companies seeking to bring advanced therapies to market.

🌟Legacy and Future Contributions 

Jiang Liqun’s legacy lies in his relentless pursuit of innovation and excellence in pharmaceutical research. His groundbreaking work in drug delivery systems has already influenced the development of treatments for high-altitude pulmonary edema and other respiratory conditions. Looking ahead, Jiang aims to expand his research into broader areas of pulmonary medicine, focusing on the use of biotechnology and nanotechnology in drug development. He envisions a future where precision medicine and targeted therapies play a pivotal role in treating respiratory diseases, improving outcomes for patients worldwide. Jiang is committed to mentoring the next generation of researchers and fostering collaborations that advance the frontiers of pharmaceutical science.

🌟Final Thoughts 

With a career marked by innovation, dedication, and impactful contributions, Liqun Jiang exemplifies the qualities of a trailblazing researcher. His work continues to shape the future of respiratory medicine, leaving an indelible mark on both academia and industry. Through his ongoing efforts, Jiang inspires a new wave of scientific inquiry and collaboration, ensuring his legacy will resonate for years to come.

📖Notable Publications

Pressure-sensitive multivesicular liposomes as a smart drug-delivery system for high-altitude pulmonary edema
  • Authors : Li, H., Liu, S., Dai, W., Jin, F., Jiang, L.
  • Journal: Controlled Release
  • Year: 2024
Inhalation of panaxadiol alleviates lung inflammation via inhibiting TNFA/TNFAR and IL7/IL7R signaling between macrophages and epithelial cells
  • Authors : Wang, Y., Wei, H., Song, Z., Shu, Q., Xie, Y.
  • Journal: Ginseng Research
  • Year: 2024
Dry Powder Formulations for Inhalation Require a Smaller Aerodynamic Diameter for Usage at High Altitude
A large particle size is required by a nano/micron sized-fluticasone propionate inhalable suspension for asthma treatment
A simple liposome-based bionic bacterium for tumor treatment by re-education of tumor-associated microphages in combination with chemotherapy

Assoc Prof Dr. Mohammed Saddik |Formulation Science |Best Researcher Award

Assoc Prof Dr. Mohammed Saddik|Formulation Science |Best Researcher Award|

Assoc Prof Dr. Mohammed Saddik atFaculty of Pharmacy, Sohag University, Egypt

PROFILE  

 

Orcid

Early Academic Pursuits 🎓

Mohammed Sherif Saddik Ibrahim began his academic journey with a strong foundation in pharmaceutical sciences. He earned his Bachelor of Pharmaceutical Sciences from the Faculty of Pharmacy, Assiut University, Egypt, on July 22, 2006. His dedication to the field was evident early on, as he quickly advanced to pursue postgraduate studies. By July 24, 2011, he had obtained his Master’s degree in Pharmaceutical Sciences, specializing in pharmaceutics. His master’s thesis, titled “Formulation and Clinical Evaluation of Some Topical Pharmaceutical Dosage Forms of Phenytoin,” highlighted his interest in the clinical applications of pharmaceuticals. Not stopping there, Mohammed continued his academic pursuits, earning a Doctor of Pharmaceutical Sciences (Ph.D.) in Pharmaceutics from Assiut University on January 24, 2017. His doctoral research focused on the “Formulation and Clinical Evaluation of Some Topical Pharmaceutical Dosage Forms of Methylene Blue for Photodynamic Therapy,” showcasing his commitment to innovative therapeutic solutions.

Professional Endeavors 🧑‍🏫

Dr. Mohammed Sherif Saddik Ibrahim’s professional career is marked by his continuous advancement in academia and clinical practice. He began as a Pharmacist at Al-Azhar University Hospital, Faculty of Medicine, Assiut University, where he worked from July 24, 2007, to October 11, 2014. This role allowed him to gain practical experience in the pharmaceutical field, which he later integrated into his teaching and research.

In 2014, Mohammed transitioned to an academic role at Sohag University, Egypt, where he served as an Assistant Lecturer of Pharmaceutics and Clinical Pharmacy until February 26, 2017. Following his Ph.D., he was promoted to Lecturer in the same department, a position he held until June 27, 2022. His excellence in teaching and research led to his appointment as an Associate Professor of Pharmaceutics and Clinical Pharmacy at Sohag University on June 29, 2022, where he continues to contribute to the field. Additionally, since September 13, 2022, Mohammed has been coordinating the Clinical Pharmacy Program at Sohag University, further cementing his role as a leader in pharmacy education.

Contributions and Research Focus 💡

Dr. Mohammed Sherif Saddik Ibrahim’s research is centered around the formulation and clinical evaluation of pharmaceutical dosage forms. His work has significant implications for enhancing the therapeutic efficacy of drugs and improving patient outcomes. One of his notable research contributions includes the development of topical pharmaceutical dosage forms for photodynamic therapy, specifically using methylene blue. This research is particularly important for its potential in treating various skin conditions and diseases through non-invasive methods.

Mohammed’s innovative approach is also evident in his work on drug delivery systems. He has supervised multiple postgraduate students, guiding them in research that explores novel drug formulations and delivery methods. His expertise in handling lab animals and conducting clinical studies further supports his research goals, particularly in designing dosage forms that are both effective and patient-friendly.

Accolades and Recognition 🏆

Throughout his career, Dr. Mohammed Sherif Saddik Ibrahim has received recognition for his contributions to pharmaceutical sciences. His work has led to several patents, including those for sulfasalazine-loaded zinc oxide nanoparticles for the treatment of ulcerative colitis (US11730759B1) and a polymeric clotrimazole biofilm for the treatment of otomycosis (US11844781B1). These patents reflect his innovative thinking and commitment to developing new therapeutic solutions.

His academic contributions have also been recognized through his participation in significant conferences. Notably, he presented at the NUB 2nd Conference of Scientific Research in Pharmacy Future Insight at the Faculty of Pharmacy, Nahda University, in March 2019, and the 1st Conference of Pharmaceutical Sciences at Badr University in Cairo, held online in November 2021. These platforms allowed him to share his research findings with the broader scientific community and gain insights into the latest developments in pharmaceutical sciences.

Impact and Influence 🌍

Dr. Mohammed Sherif Saddik Ibrahim’s impact on the field of pharmaceutics extends beyond his research. As an educator, he has taught a wide range of courses at Sohag University, including Pharmaceutics, Physical Pharmacy, Community Pharmacy, Controlled Drug Delivery, and Pharmaceutical Legislations & Regulatory Affairs. His teaching not only imparts knowledge but also inspires the next generation of pharmacists and researchers. Mohammed’s role as a coordinator of the Clinical Pharmacy Program at Sohag University further amplifies his influence, as he shapes the curriculum and ensures that students receive a comprehensive and up-to-date education.

His contributions to research have also had a tangible impact on patient care. The dosage forms and drug delivery systems he has developed have the potential to improve the treatment of various conditions, from skin diseases to chronic illnesses like ulcerative colitis. By focusing on patient-centered research, Mohammed’s work is helping to bridge the gap between laboratory research and clinical practice, ultimately benefiting patients in Egypt and beyond.

Legacy and Future Contributions 🚀

As a progressive professional with a strong research background, Dr. Mohammed Sherif Saddik Ibrahim is poised to continue making significant contributions to the field of pharmaceutical sciences. His commitment to education and research, particularly in the area of drug delivery systems, positions him as a leader in the field. Looking ahead, Mohammed aims to further explore the green synthesis of nanomaterials and their application in drug delivery. His goal is to develop innovative pharmaceutical dosage forms that are not only effective but also environmentally sustainable.

Mohammed’s vision for the future includes expanding his research to address emerging medical challenges, such as diabetes and leukemia. With two patents already in progress for treatments in these areas, he is actively working towards solutions that could have a profound impact on global health. His determination to identify innovative approaches and improve medical outcomes drives his research and teaching efforts.

Conclusion 🌟

Dr. Mohammed Sherif Saddik Ibrahim’s career is a testament to his dedication to advancing pharmaceutical sciences. From his early academic pursuits to his current role as an Associate Professor and researcher, he has consistently sought to improve drug delivery systems and therapeutic efficacy. His contributions to education, research, and patient care have left a lasting impact, and his future work promises to bring even more innovative solutions to the field. As he continues to explore new frontiers in pharmaceutics, Mohammed’s legacy as a visionary educator and researcher will undoubtedly grow.

🎓Publication 

Formulation and evaluation of azithromycin-loaded silver nanoparticles for the treatment of infected wounds.

  • Authors   :Saddik MS; Al-Hakkani MF; Abu-Dief AM; Mohamed MS; Al-Fattah IA; Mahmoud Makki; El-Mokhtar MA; Marwa A. Sabet; Amin MS; Ahmed HA et al...
  • Journal    :pharmaceutics
  • Year         :2024

Characterization and Bio-Evaluation of the Synergistic Effect of Simvastatin and Folic Acid as Wound Dressings on the Healing Process

  • Authors   : Mahmoud A. Hashem; Badriyah S. Alotaibi; Mahmoud M.A. Elsayed; Manal E. Alosaimi; Amal K. Hussein; Maram Abduljabbar; Kyung-Tae Lee; Hamdy Abdelkader; Mohamed A. El-Mokhtar ; Ahmed Hassan et al.
  • Journal    :Pharmaceutics
  • Year         :2023

Synthesis, Physicochemical Characterization using a Facile Validated HPLC Quantitation Analysis Method of 4-Chloro-phenylcarbamoyl-methyl Ciprofloxacin and Its Biological Investigations

  • Authors   :Mostafa F. Al-Hakkani; Nourhan Ahmed; Alaa A. Abbas; Mohammad H. A. Hassan; Hossameldin A. Aziz; Ali M. Elshamsy; Hazim O. Khalifa; Mohamed A. Abdelshakour; Mohammed S. Saddik; Mahmoud M. A. Elsayed et al.
  • Journal    :Molecular Sciences
  • Year         :2023

Development of Novel Nano-Sized Imine Complexes Using Coriandrum sativum Extract: Structural Elucidation, Non-Isothermal Kinetic Study, Theoretical Investigation and Pharmaceutical Applications

  • Authors   : Shimaa Hosny; Randa F. Abd El-Baki; Zeinab H. Abd El-Wahab; Gamal A. Gouda; Mohammed S. Saddik; Ateyatallah Aljuhani; Ahmed M. Abu-Dief.
  • Journal    :Molecular Sciences
  • Year         :2023

In vitro and in vivo synergistic wound healing and anti-methicillin-resistant Staphylococcus aureus (MRSA) evaluation of liquorice-decorated silver nanoparticles

  • Authors   :Hamdoon Mohammed; Mohammed A. Amin; Gamal Zayed; Yassar Hassan; Mohamed El-Mokhtar; Mohammed S. Saddik..
  • Journal    : Antibiotics
  • Year         :2023

Ms. Nokubonga Zulu|Formulation Science | Best Researcher Award

Ms. Nokubonga ZulFormulation Science |Best Researcher Award|

Ms. Nokubonga Zulu at Johannesburg,South Africa

PROFILE  

scopus

 

Early Academic Pursuits 🎓

Nokubonga Given Zulu’s journey into the field of metallurgy began with a strong academic foundation laid at the University of Johannesburg, one of South Africa’s leading institutions. She pursued a Bachelor of Engineering Technology (BEng Tech Hons) in Extraction Metallurgy, a rigorous program that provided her with the essential knowledge and skills required in the field. Nokubonga demonstrated exceptional dedication and discipline throughout her undergraduate studies, which culminated in her graduation. Her passion for metallurgy, coupled with her strong academic performance, set the stage for her future endeavors.

Following her undergraduate studies, Nokubonga continued to excel academically by enrolling in a Master of Engineering (MEng) degree in Extraction Metallurgy at the same university. She completed this program with distinction, a testament to her hard work and commitment to her field. Her master’s research focused on Biomining, particularly bioflotation, which is a cutting-edge area of study within metallurgical engineering. This research not only broadened her knowledge but also positioned her as a budding expert in the emerging field of biometallurgy.

Professional Endeavors 💼

Nokubonga’s professional journey began while she was still a student. She gained invaluable experience working in various roles at the University of Johannesburg, including as a Mineral Processing Lab Assistant and an Analytical Lab Assistant. These positions allowed her to develop a practical understanding of metallurgical processes and laboratory techniques. She also served as an Academic Tutor, where she helped students grasp complex concepts in process engineering, research methodology, and metallurgical projects. Her role as a Research Assistant further honed her skills in conducting experiments and contributing to academic research, which proved instrumental in her subsequent career.

In 2022, Nokubonga expanded her professional horizons by undertaking a three-month training program as a Trainee Metallurgist at the Kibali Gold Mine, operated by Barrick Gold Corporation in the Democratic Republic of Congo. This experience exposed her to real-world applications of mineral processing, hydrometallurgy, and pyrometallurgy. Working at one of the largest gold mines in Africa, Nokubonga deepened her understanding of the practical challenges faced in the industry, enhancing her critical thinking and problem-solving skills.

Currently, Nokubonga is working as a Graduate Metallurgist at Siyanda Bakgatla Platinum Mine. In this role, she is responsible for plant inspections and tracking process recipes based on day-to-day changes in the plant. This position allows her to apply her academic knowledge in a practical setting, contributing to the optimization and efficiency of metallurgical processes in the platinum mining sector.

Contributions and Research Focus 🔬

Nokubonga’s contributions to the field of metallurgy are noteworthy, particularly in the area of biomining. Her master’s research on bioflotation, a process that uses biological agents to separate valuable minerals from ores, has the potential to revolutionize the field by providing more sustainable and environmentally friendly methods of mineral extraction. This research has not only advanced the academic understanding of biomining but has also positioned Nokubonga as a leader in this niche field.

Her academic contributions include five published research outputs, comprising two journal articles and three conference papers. These publications reflect her deep engagement with the metallurgical community and her commitment to advancing knowledge in her field. Nokubonga’s work is currently under further review, indicating that she continues to push the boundaries of her research, with the potential for more significant contributions in the future.

Accolades and Recognition 🏆

Nokubonga’s academic excellence and professional achievements have not gone unnoticed. Completing her MEng degree with distinction is a significant accolade that underscores her dedication and expertise. While specific awards and recognitions are not detailed in the provided information, her progression from a student to a respected professional in the field is itself a testament to her capabilities and the recognition she has garnered within the academic and professional communities.

Impact and Influence 🌍

Nokubonga Given Zulu’s impact extends beyond her immediate academic and professional achievements. As a South African female in a traditionally male-dominated field, she serves as a role model and inspiration for other young women aspiring to enter the fields of engineering and metallurgy. Her dedication to acquiring knowledge and her pursuit of excellence have positioned her as a leader in her field, with the potential to influence future generations of metallurgists.

Her work in biomining, particularly bioflotation, has the potential to significantly impact the metallurgical industry by promoting more sustainable and environmentally friendly practices. This focus on innovation and sustainability aligns with global trends in mining and metallurgy, further enhancing her influence on the field.

Legacy and Future Contributions 🚀

Looking ahead, Nokubonga’s aspirations include pursuing a Ph.D. with a focus on Geometallurgy and Biometallurgy. This next step in her academic journey will allow her to further specialize in her areas of interest and contribute even more significantly to the field. Her ongoing research and future studies are expected to yield new insights and innovations, further solidifying her legacy as a pioneer in biomining.

Nokubonga’s legacy will be one of dedication, discipline, and a relentless pursuit of knowledge. As she continues to advance in her career, her contributions to both academia and industry are likely to leave a lasting impact on the field of metallurgy. Her journey serves as an inspiration to others, particularly young women, who aspire to make their mark in science and engineering.

Conclusion 🌟

Nokubonga Given Zulu is a shining example of what can be achieved through dedication, discipline, and a passion for learning. Her academic and professional journey reflects a commitment to excellence and a desire to make meaningful contributions to the field of metallurgy. As she continues to pursue her goals, her impact on the field and her legacy as a pioneering female metallurgist are set to grow, inspiring future generations to follow in her footsteps.

🎓Publication 

Optimization of Upper group 2 flotation using Acidithiobacillus ferrooxidans as a modifier

  • Authors   :Zulu, N.G., Thethwayo, B.M., Madiba, M.
  • Journal    :Minerals Engineering
  • Year         :2024

THERMODYNAMIC EFFECTS OF TEMPERATURE DURING ROASTING OF CHROMITE FOR SODIUM CHROMATE SALTS FORMATION

  • Authors   :Mvita, M.J., Zulu, N.G., Thethwayo, B., Makhamisa, S.
  • Journal    :MetalurgijaT
  • Year         :2024

Prof Dr. THAWATCHAI PHAECHAMUD| Drug Delivery Systems | Best Researcher Award-1299

Prof Dr. THAWATCHAI PHAECHAMUD, Drug Delivery Systems ,Best Researcher Award

Prof Dr. THAWATCHAI PHAECHAMUD atSilpakorn University,Thailand

PROFILE  

Google scholar 

Scopus

Orcid

Early Academic Pursuits 🎓

Thawatchai Phaechamud, Mr., embarked on his academic journey at the Faculty of Pharmacy, Silpakorn University, Thailand, where he earned his Bachelor of Pharmacy (B.Pharm) degree in 1991. Demonstrating a strong interest in pharmaceutical sciences from an early stage, he advanced his studies at the Faculty of Pharmaceutical Sciences, Chulalongkorn University. There, he completed his Master of Science (M.Sc.) in Manufacturing Pharmacy in 1995, with a thesis focused on the “Effect of variables in chitosan film on propranolol hydrochloride coated tablets.” His academic journey culminated in a Ph.D. in Pharmaceutics from the same institution in 1999. His doctoral thesis, titled “Film-coating of chitosan onto propranolol hydrochloride tablet: Approach to fast and extended drug release,” laid the foundation for his future contributions to the field of pharmaceutics, particularly in drug delivery systems.

Professional Endeavors 🧑‍🏫

Mr. Phaechamud began his professional career as a Lecturer at the Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, from 1991 to 1993. During this period, he honed his teaching skills and laid the groundwork for a lifelong commitment to academia. From 1994 to 1996, he served as a research student at the Faculty of Pharmaceutical Sciences, Chulalongkorn University, further deepening his research capabilities. His academic prowess earned him a position as a Visiting Scientist at the Department of Pharmaceutics, Toyama Medical & Pharmaceutical University in Japan from November 1997 to January 1998.

Upon completing his Ph.D., Mr. Phaechamud returned to Silpakorn University, where he served as an Assistant Professor from 1999 to 2003 in the Department of Pharmaceutical Technology. His dedication to teaching and research led to his promotion to Associate Professor in 2004, a position he has held ever since. His roles have expanded over the years, including serving as the Head of the Department of Pharmaceutical Technology from 2008 to 2009 and Chairman of the Pharmaceutical Engineering Doctoral Program from 2017 to 2018. Since 2018, Mr. Phaechamud has held the esteemed title of Professor in the Department of Industrial Pharmacy, Faculty of Pharmacy at Silpakorn University.

Contributions and Research Focus 🔬

Mr. Phaechamud’s research interests are diverse, focusing on various aspects of pharmaceutical sciences. His work primarily revolves around controlled drug delivery systems, in situ forming gels, matrix film and tablet characterizations, herbal preparation and development, pharmaceutical film coating, and pharmaceutical excipient characterization. He has made significant contributions to the development of controlled drug delivery systems, a field that aims to enhance the efficacy and safety of medications by controlling the rate, time, and place of drug release.

His expertise in polymeric film characterization and pharmaceutical excipient characterization has been instrumental in advancing the understanding of drug delivery mechanisms. His work on in situ forming gels and matrix films has paved the way for innovative drug delivery solutions, particularly in the treatment of chronic conditions where sustained drug release is crucial.

Accolades and Recognition 🏆

Throughout his illustrious career, Mr. Phaechamud has received numerous accolades and recognition for his contributions to pharmaceutical sciences. In June 2006, he was honored as a TRF Research Scholar by The Thailand Research Fund, a prestigious recognition of his research excellence. His leadership in the “Development of standard extract of SC for pharmaceutical and cosmetic applications” research program at Silpakorn University in 2008-2009 further solidified his reputation as a leading researcher in his field.

His publications in high-impact journals reflect the quality and impact of his research. Notable publications include works in the International Journal of Biological Macromolecules, Polymers, AAPS PharmSciTech, and Pharmaceutics, where his research on topics such as transdermal and periodontal pocket drug delivery systems, in situ gels, and solvent-removal zein-based in situ gels has garnered significant attention.

Impact and Influence 🌍

Mr. Phaechamud’s research has had a profound impact on the field of pharmaceutics, particularly in the area of drug delivery systems. His work on controlled drug delivery systems and in situ forming gels has influenced the development of new therapeutic approaches that improve patient outcomes by ensuring more effective and targeted drug delivery.

His influence extends beyond research; as an educator, he has mentored countless students, many of whom have gone on to become leaders in the pharmaceutical industry and academia. His teachings on modified release solid dosage forms, controlled drug delivery systems, and polymer degradation have been instrumental in shaping the next generation of pharmaceutical scientists.

Legacy and Future Contributions 🌟

Mr. Phaechamud’s legacy is one of innovation, dedication, and excellence in the field of pharmaceutical sciences. His work has not only advanced the understanding of drug delivery mechanisms but also paved the way for new therapeutic solutions that have the potential to improve the lives of millions of patients worldwide.

As he continues his work at Silpakorn University, Mr. Phaechamud is

🎓Publication 

Moist heat treatment on physicochemical change of chitosan salt films

  • Authors   :Garnpimol C Ritthidej, Thawatchai Phaechamud, Tamotsu Koizumi
  • Journal    :International journal of pharmaceutics
  • Year         :2002

Gentamicin sulfate-loaded porous natural rubber films for wound dressing

    • Authors :Thawatchai Phaechamud, Pongsathorn Issarayungyuen, Wiwat Pichayakorn
    • Journal   :International journal of biological macromolecules
    • Year       : 2016

Sustained-release from layered matrix system comprising chitosan and xanthan gum

  • Authors  :Thawatchai Phaechamud, Garnpimol C Ritthidej
  • Journal    :Drug development and industrial pharmacy
  • Year         :  2007

The study of antioxidant capacity in various parts of Areca catechu L.

  • Authors  :Penpun Wetwitayaklung, Thawatchai Phaechamud, Chutima Limmatvapirat, Sindhchai Keokitichai
  • Journal   :Naresuan University Journal: Science and Technology (NUJST)
  • Year        :   2006

Antibacterial activity and drug release of chitosan sponge containing doxycycline hyclate

  • Authors  :Thawatchai Phaechamud, Juree Charoenteeraboon
  • Journal   :Aaps PharmSciTech
  • Year        :  2008